Announcement of Fujian Aonong Biotechnology Group Co., Ltd. on applying for financing credit lines from financial institutions in 2026

Securities code: 603363 Securities abbreviation: Aonong Biotechnology Announcement number: 2025-106

Fujian Aonong Biotechnology Group Co., Ltd.

Announcement on applying for financing credit lines from financial institutions in 2026

The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.

Fujian Aonong Biotechnology Group Co., Ltd. (hereinafter referred to as the "Company") held the 20th meeting of the fourth board of directors on December 4, 2025, and reviewed and approved the "Proposal on Applying for Financing Credit Lines from Financial Institutions in 2026" and agreed that the company (including the company's wholly-owned and controlled subsidiaries) will continue to apply for financing credits from financial institutions including but not limited to banks, financial leasing companies and other financial institutions in 2026. The applied credit limit shall not exceed RMB 30 Billion yuan, the company can use its own assets to actually use the above credit line to set up mortgages and pledge guarantees with financial institutions. The resolution to apply for the financing credit line is valid from the date of review and approval by the shareholders' meeting to the date of the shareholders' meeting to review the same matters in 2027.

Applying for the above-mentioned financing credit line from a financial institution is mainly to meet the production and operation needs of the company and its wholly-owned and controlled subsidiaries. The scale of the line is determined based on the existing line and considering the needs of business development and growth. For specific matters related to credit granting, the company's relevant management departments are authorized to communicate with financial institutions based on actual needs for implementation, and the company's legal representative is authorized to sign various legal documents related to credit granting. Within the credit period, the credit limit can be recycled. The financing credit limit applied for by the company is not equal to the actual financing amount of the company. The actual financing amount within the above credit limit shall be based on the actual financing amount between each financial institution and the company. The above matters still need to be submitted to the company's shareholders' meeting for review.

Announcement is hereby made.

Board of Directors of Fujian Aonong Biotechnology Group Co., Ltd.

December 5, 2025